top of page
Search

Jonathan Langley Appointment

  • Aug 5, 2020
  • 1 min read

Updated: Mar 29, 2022

ATXA Therapeutics & PAH Hope are delighted to welcome Jonathan Langley on board as a non-executive director. Jonathan has vast experience in Pulmonary Arterial Hypertension.


 
 
 

Comments

Small Logo Gray.jpg

© 2026 ATXA Therapeutics Ltd. All Rights Reserved.

  • LinkedIn
  • X
  • Facebook
  • YouTube

TERMS OF USE

PRIVACY POLICY

Company number: 561857

UCD Conway Institute,

University College Dublin,

Belfield, Dublin 4, Ireland

Tel: +353 (0)1 525 2829

Contact Us

bottom of page